[HTML][HTML] Network pharmacology: curing causal mechanisms instead of treating symptoms
For complex diseases, most drugs are highly ineffective, and the success rate of drug
discovery is in constant decline. While low quality, reproducibility issues, and translational …
discovery is in constant decline. While low quality, reproducibility issues, and translational …
[HTML][HTML] Current advances in RNA therapeutics for human diseases
H Zogg, R Singh, S Ro - International journal of molecular sciences, 2022 - mdpi.com
Following the discovery of nucleic acids by Friedrich Miescher in 1868, DNA and RNA were
recognized as the genetic code containing the necessary information for proper cell …
recognized as the genetic code containing the necessary information for proper cell …
Cystic fibrosis: a review
T Ong, BW Ramsey - Jama, 2023 - jamanetwork.com
Importance Cystic fibrosis, a genetic disorder defined by variants in the cystic fibrosis
transmembrane conductance regulator (CFTR) gene, affects more than 30 000 individuals in …
transmembrane conductance regulator (CFTR) gene, affects more than 30 000 individuals in …
[HTML][HTML] Non-coding RNAs in human health and disease: potential function as biomarkers and therapeutic targets
T Loganathan, GP Doss C - Functional & integrative genomics, 2023 - Springer
Human diseases have been a critical threat from the beginning of human history. Knowing
the origin, course of action and treatment of any disease state is essential. A microscopic …
the origin, course of action and treatment of any disease state is essential. A microscopic …
First contact: the role of respiratory cilia in host-pathogen interactions in the airways
LE Kuek, RJ Lee - … Journal of Physiology-Lung Cellular and …, 2020 - journals.physiology.org
Respiratory cilia are the driving force of the mucociliary escalator, working in conjunction
with secreted airway mucus to clear inhaled debris and pathogens from the conducting …
with secreted airway mucus to clear inhaled debris and pathogens from the conducting …
Overcoming barriers in non-viral gene delivery for neurological applications
A Tasset, A Bellamkonda, W Wang, I Pyatnitskiy… - Nanoscale, 2022 - pubs.rsc.org
Gene therapy for neurological disorders has attracted significant interest as a way to reverse
or stop various disease pathologies. Typical gene therapies involving the central and …
or stop various disease pathologies. Typical gene therapies involving the central and …
[HTML][HTML] Gene therapy for cystic fibrosis: Challenges and prospects
H Sui, X Xu, Y Su, Z Gong, M Yao, X Liu… - Frontiers in …, 2022 - frontiersin.org
Cystic fibrosis (CF) is a life-threatening autosomal-recessive disease caused by mutations in
a single gene encoding cystic fibrosis transmembrane conductance regulator (CFTR). CF …
a single gene encoding cystic fibrosis transmembrane conductance regulator (CFTR). CF …
Functional correction of CFTR mutations in human airway epithelial cells using adenine base editors
S Krishnamurthy, S Traore, AL Cooney… - Nucleic acids …, 2021 - academic.oup.com
Mutations in the CFTR gene that lead to premature stop codons or splicing defects cause
cystic fibrosis (CF) and are not amenable to treatment by small-molecule modulators. Here …
cystic fibrosis (CF) and are not amenable to treatment by small-molecule modulators. Here …
A review of the tortuous path of nonviral gene delivery and recent progress
Gene therapy encompasses the transfer of exogenous genetic materials into the patient's
target cells to treat or prevent diseases. Nevertheless, the transfer of genetic material into …
target cells to treat or prevent diseases. Nevertheless, the transfer of genetic material into …
Nanoparticle delivery systems with cell-specific targeting for pulmonary diseases
Respiratory disorders are among the most important medical problems threatening human
life. The conventional therapeutics for respiratory disorders are hindered by insufficient drug …
life. The conventional therapeutics for respiratory disorders are hindered by insufficient drug …